Bristol-Myers

BMY NYSE
46.81
-0.49
-1.04%
After Hours: 46.88 +0.07 +0.15% 17:35 05/24 EDT
Open
47.40
Prev Close
47.30
High
47.54
Low
46.78
Volume
9.47M
Avg Vol (3M)
17.96M
52 Week High
63.69
52 Week Low
44.30
% Turnover
0.58%
Market Cap
76.57B
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers Bristol-Myers BMY stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.
MORE >

Recently

Name
Price
%Change